Incidence and Predictors of Secondary Failure to Biologic Therapy in Patients with Psoriatic Arthritis [0.03%]
生物制剂治疗银屑病关节炎继发失效的发病率和预测因素
Fadi Kharouf,Ali AlHadri,Shangyi Gao et al.
Fadi Kharouf et al.
Objective: Secondary failure to biologic DMARDs (bDMARDs) is challenging and contributes to the complexity of managing psoriatic arthritis (PsA). We aimed to define the frequency and incidence of this phenomenon in PsA an...
Rethinking HLA-B27 Testing: What HLA-B27 Can- and Cannot-Tell Us [0.03%]
HLA-B27检测再思考：解读HLA-B27的能与不能
Marie Beaufrère,Bilade Cherqaoui,Félicie Costantino
Marie Beaufrère
HLA-B27: a cornerstone in spondyloarthritis Nearly 50 years after its discovery as a major genetic risk factor for spondyloarthritis (SpA),1 the precise contribution of HLA-B27 to disease development and progression remains only partially u...
Assessment of giant cell arteritis-associated visual outcomes at a tertiary hospital in Ontario, Canada [0.03%]
加拿大安大略省一家三级医院评估巨细胞动脉炎相关的视力预后
Mats L Junek,Rahul Chanchlani,Amadeo R Rodriguez et al.
Mats L Junek et al.
Objective: There are limited data concerning outcomes in those with giant cell arteritis-associated vision changes (GCA, GCAVCs). We estimated the association of intravenous, compared to oral, glucocorticoids with outcome...
Ample Room for Improvement [0.03%]
改进空间很大
Mohamad Bittar,Atul Deodhar
Mohamad Bittar
Richard J Cook,Jerald F Lawless,Lily Zou
Richard J Cook
Obtaining valid real-world evidence about intervention effects from observational cohorts or administrative health records data is challenging. Visits to healthcare providers tend to occur more often during periods of increased disease acti...
Identifying resolution of clinically suspect arthralgia: a step towards understanding spontaneous reversal of an at-risk stage of rheumatoid arthritis [0.03%]
识别临床疑似关节痛的缓解情况：迈向理解类风湿性关节炎风险阶段自发逆转的第一步
Sarah J H Khidir,Elise van Mulligen,Annette H M van der Helm-van Mil
Sarah J H Khidir
Objective: Symptoms in the at-risk stage of clinically suspect arthralgia (CSA) can progress to Rheumatoid Arthritis (RA) or disappear spontaneously. The area of reversal of an at-risk stage is yet unexplored. Therefore, ...
Challenges of ASAS criteria in Real-World Colombia SpA patients. A cross-sectional study [0.03%]
ANCA相关血管炎患者应用ASAS标准的现实困境——一项横断面研究
Igor Rueda,Gustavo José Rodriguez,Ana María Santos et al.
Igor Rueda et al.
Objective: The Assessment of SpondyloArthritis international Society (ASAS) criteria classify spondyloarthritis (SpA) based on clinical presentation. Although widely applied, their performance in Colombia's population rem...
Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes [0.03%]
儿童期系统性红斑狼疮的个体及社会生态学韧性与患者特征和心理社会结局的相关性研究
Isabella Zaffino,Louise Boulard,Joanna Law et al.
Isabella Zaffino et al.
Objective: This study investigates individual and socio-ecological resilience and their relationship with sociodemographic and disease characteristics, and psychosocial patient-reported outcomes in childhood-onset systemi...
How Representative Are Data From Clinical Trials in Axial Spondyloarthritis for Women? [0.03%]
轴突型脊柱关节炎临床试验中的女性数据具有代表性吗？
Irene E van der Horst-Bruinsma,Sander I van Leuven
Irene E van der Horst-Bruinsma
GRAPPA Patient Research Partner Network Composition and Engagement: A Survey to Determine Strategic Areas for Growth [0.03%]
关于GRAPPA患者研究合作伙伴网络构成及参与度的调查：确定战略增长领域的调研报告
Christine A Lindsay,Suzanne M Grieb,Arnon Katz
Christine A Lindsay
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Patient Research Partner (PRP) Network conducted a survey to identify its key strengths and gaps, with the goal of enhancing its global reach and representa...